Necrotizing fasciitis secondary to group A streptococcus. Morbidity and mortality still high | Canada Hyperbarics Skip to main content
Case Report Can Fam Physician 2000 Canadian

Necrotizing fasciitis secondary to group A streptococcus. Morbidity and mortality still high

Leitch H, Palepu A, Fernandes C — Can Fam Physician, 2000

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reviewed existing medical literature to update doctors on how to diagnose and treat necrotizing fasciitis caused by Group A streptococcus.

What They Found

They found that a key sign of necrotizing fasciitis is severe pain that seems worse than the visible physical symptoms. Treatment involves urgent surgical removal of infected tissue along with high-dose intravenous penicillin G and clindamycin, but mortality rates remain high, ranging from 20% to 34% in larger studies. Risk factors for death include older age, existing health problems, low blood pressure, and bacteria in the bloodstream.

What This Means for Canadian Patients

For Canadian patients, this study highlights the importance of recognizing the severe pain associated with necrotizing fasciitis early, as prompt diagnosis and urgent surgical referral are critical. Aggressive treatment, including surgery and specific antibiotics, is essential to improve outcomes, especially given the high mortality rate of 20% to 34%. Patients with risk factors like advanced age or underlying illnesses should be particularly vigilant for symptoms.

Canadian Relevance

This study is highly relevant to Canada as it was published in a Canadian journal (Can Fam Physician) by Canadian authors, and mentions Ontario in its MeSH terms. No direct coverage of a Health Canada-recognized HBOT indication was identified in the abstract's findings.

Study Limitations

A key limitation of this review is that the evidence primarily came from case reports, case series, or surveys, with no randomized controlled trials available.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 10925760
Year Published 2000
Journal Can Fam Physician
MeSH Terms Aged; Anti-Bacterial Agents; Fasciitis, Necrotizing; Female; Humans; Hyperbaric Oxygenation; Immunization, Passive; Ontario; Risk Factors; Shock, Septic

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.